As featured in
View 2 jobs
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Jobs
Financials
Overview
Aroa Biosurgery develops regenerative wound and soft tissue repair products from ovine tissue. Its bioengineered materials are used in complex wound and hernia surgery worldwide. The company is listed on the Australian Securities Exchange.
News
AROA Biosurgery 2026 Annual General Meeting
AROA Biosurgery held its 2026 Annual General Meeting on Wednesday 19 August 2026. All six resolutions were carried, including: Dr Catherine Mohr was re-elected as a Non-Executive Director. Paul Shearer was elected as a Non-Executive Director. The remainin
Read more
Report
Report
AROA Biosurgery Completes Randomised Controlled Trial for Symphony; Preliminary Read-Out indicates Primary Endpoint Met
Read more
Report
First clinical evidence published on AROA's ENIVO system for surgical dead space management
AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a Novel Tissue Apposition
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Growth
Hiring Momentum
48/100
Stable
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~13 hours
08/29/2026
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
QA
100% ▲
Jobs
Apply
Quality Assurance Engineer
14 days agoIn office • Full-Time • 3+ years exp • Bachelor's Degree • Auckland
Apply
